The high throughput screening market had an estimated market share worth US$ 25.7 billion in 2023, and it is predicted to reach a global market valuation of US$ 92.5 billion by 2034, growing at a CAGR of 10.5% from 2024 to 2034.
Demand Analysis of High Throughput Screening
| Report Attribute | Details |
|---|---|
| Estimated Market Value in 2023 | US$ 25.7 billion |
| Expected Market Value in 2024 | US$ 29 billion |
| Projected Forecast Value in 2034 | US$ 92.5 billion |
| Anticipated Growth Rate from 2024 to 2034 | 10.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for the high throughput screening market was estimated to reach a valuation of US$ 3.3 billion in 2019, according to a report from Future Market Insights (FMI). From 2019 to 2023, the high throughput screening market witnessed significant growth, registering a CAGR of 14%.
| Historical CAGR 2019 to 2023 | 14% |
|---|---|
| Forecast CAGR 2024 to 2034 | 10.5% |
Rapid drug discovery solutions are more important than ever since complex illnesses like cancer and neurological disorders are becoming more common. Rapid evaluation of vast chemical libraries by high throughput screening methods is essential for identifying possible treatment candidates. Adcetris from Seagen, for instance, is a prime illustration of this, as it is the outcome of stringent screening initiatives meant to further targeted cancer treatments.
Increasing Focus on Drug Repurposing to Bolster Growth
The growing emphasis on drug repurposing is another important driver of the market. Drug development time and expenses are decreased by the use of high throughput screening to find medications already on the market with untapped therapeutic potential.
Repurposing efforts, for instance, led to the discovery of sildenafil's use for erectile dysfunction, demonstrating the importance of high throughput screening in this approach.
Principal Consultant
Costly Infrastructure and False Positives to Impede the Market Growth
This section focuses on providing detailed analysis of two particular market segments for high throughput screening, the dominant technology and the significant application. The two main segments discussed below are the ultra high throughput screening and target identification.
| Technology | Ultra-high-throughput Screening |
|---|---|
| CAGR from 2024 to 2034 | 12% |
The ultra-high-throughput screening segment is anticipated to expand with a 12% CAGR through 2034. Ultra-high-throughput screening is likely to become the market's leading technology due to its unprecedented ability to screen millions of compounds quickly.
This makes it possible to thoroughly explore chemical space and raises the possibility of finding new medication options. Improvements in automation and microfluidics increase throughput and efficiency even further, making ultra-high-throughput screening the method of choice for extensive drug development projects.
| Application | Target Identification |
|---|---|
| CAGR from 2024 to 2034 | 12% |
During the forecast period, the target identification segment is likely to garner a 12% CAGR. Due to its capacity to swiftly assess huge chemical libraries against a variety of biological targets, high throughput screening will be mostly utilized for target identification.
This accelerates the drug development process by making it easier to identify promising therapeutic candidates with high specificity and effectiveness. Technological developments in automation and robots have improved efficiency and throughput, making high throughput screening a vital technique for target identification in drug discovery.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
This section will go into detail on the high throughput screening markets in a few key countries, including the United States, the United Kingdom, China, Japan and South Korea. This segment will focus on the key factors that are driving up demand in these countries for high throughput screening.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| The United States | 12.6% |
| The United Kingdom | 12.9% |
| China | 13.1% |
| Japan | 13.7% |
| South Korea | 14.9% |
The United States high throughput screening ecosystem is anticipated to gain a CAGR of 12.6% through 2034. The strong biotechnology startup setting in the United States, which specializes in high throughput screening technologies, is another distinctive feature of the country.
These businesses, which use innovative approaches and disruptive technology to propel improvements in drug development and precision medicine, frequently come out of well-known research universities and biotech centers.
To further drug development, Relay Therapeutics employs state-of-the-art computational and experimental methodologies. Their approach combines molecular dynamics simulations and high throughput screening to find allosteric pockets on proteins, allowing the development of new medicines that target difficult disease processes.
The high throughput screening market in the United Kingdom is expected to expand with a 12.9% CAGR through 2034. The use of high throughput screening technology into drugs repurposing initiatives is a significant component in the United Kingdom.
The use of these technologies in the United Kingdom permits rapid evaluation of vast chemical libraries, which is important given the increased emphasis on identifying novel therapeutic applications for current medications to effectively address unmet medical needs. This promotes the process of identifying possible repurposing candidates.
The high throughput screening ecosystem in China is anticipated to develop with a 13.1% CAGR from 2024 to 2034.
China's biopharmaceutical industry is expanding rapidly as a result of increasing investment in research and development, favorable government regulations, and a big pool of experienced experts.
In order to fulfill market demands and accelerate drug discovery procedures, high throughput screening methods are becoming more and more in demand.
The high throughput screening industry in Japan is anticipated to reach a 13.7% CAGR from 2024 to 2034. The high throughput screening industry in Japan is driven by government efforts aimed at advancing customized healthcare and precision medicine.
High throughput screening methods are in more demand as a result of the emphasis on using genetic information and customized therapies to enable quick and precise analysis of patient samples for individualized treatment plans.
The high throughput screening ecosystem in South Korea is likely to evolve with a 14.9% CAGR during the forecast period. The biopharmaceutical sector in South Korea is growing quickly due to advances in biotechnology and a growing emphasis on developing new treatments.
Technologies for high throughput screening are essential for accelerating the drug development process, satisfying patient demand for novel medicines, and expanding the market.
There may be times when organizations in this market have a falling growth curve. In such cases, they may already have tactical measures in place to counteract poor growth and carve a positive growth curve. They can use the following strategies:
In response to a downturn in growth
Advanced Technological Integration
Agilent Technologies provides innovative high-throughput screening platforms outfitted with cutting-edge technologies such as microfluidics along with automation. This enables speedy and precise screening of massive chemical libraries.
Flexibility and Customization
PerkinElmer, Inc. specializes in specialized high-throughput screening solutions for unique research needs and applications. Their systems enable researchers to customize procedures and workflows based on their specific needs, providing flexibility and efficiency.
Extensive Service Offerings
For researchers and pharmaceutical businesses, Thermo Fisher Scientific offers a one-stop shop for full high-throughput screening services, comprising assay creation, compound management, as well as data analysis.
The leading companies in the high throughput screening industry are concentrating on a few crucial tactics. Investing consistently in research and development to create novel screening methods and platforms is one of them. To increase their product options and market reach, they also place a high priority on strategic partnerships with pharmaceutical firms and research institutes.
In order to improve their competitive position and gain access to emerging technologies and information in the market, being involved in mergers and acquisitions is also a critical priority. They also stress the need for customer-centric strategies for efficiently satisfying a range of demands. The key players in this market include:
Significant advancements in the high throughput screening market are being made by key market participants, and these include:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 10.5% from 2024 to 2034 |
| Market value in 2024 | US$ 29 billion |
| Market value in 2034 | US$ 92.5 billion |
| Base Year for Estimation | 2023 |
| Historical Data | 2019 to 2023 |
| Forecast Period | 2024 to 2034 |
| Quantitative Units | US$ billion for value |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Countries Profiled |
|
| Key Companies Profiled |
|
| Customization Scope | Available on Request |
The high throughput screening market is expected to garner a 10.5% CAGR from 2024 to 2034.
By 2024, the global high throughput screening market is likely to gain US$ 29 billion.
By 2034, the high throughput screening market valuation is likely to reach a sum of US$ 92.5 billion.
The high throughput screening industry in the United States is likely to garner a 12.6% CAGR during the forecast period.
Target identification is the top application for the high throughput screening and likely to garner a 12% CAGR through 2034.
The ultra-high-throughput screening technology is the dominant technology in this market, anticipated to expand with a 12.1% CAGR through 2034.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034
5.3.1. Ultra-high-throughput Screening
5.3.2. Cell-based Assays
5.3.3. Lab-on-a-chip
5.3.4. Label-free Technology
5.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Applications
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Applications, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Applications, 2024 to 2034
6.3.1. Target Identification
6.3.2. Primary Screening
6.3.3. Toxicology
6.4. Y-o-Y Growth Trend Analysis By Applications, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Applications, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Products and Services
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Products and Services, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Products and Services, 2024 to 2034
7.3.1. Instruments
7.3.2. Reagents and Kits
7.3.3. Services
7.4. Y-o-Y Growth Trend Analysis By Products and Services, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Products and Services, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
8.3.1. Pharmaceutical and Biotechnology Firms
8.3.2. Academia and Research Institutes
8.3.3. Contract Research Organizations
8.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Technology
10.2.3. By Applications
10.2.4. By Products and Services
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Technology
10.3.3. By Applications
10.3.4. By Products and Services
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Technology
11.2.3. By Applications
11.2.4. By Products and Services
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Applications
11.3.4. By Products and Services
11.3.5. By End User
11.4. Key Takeaways
12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Technology
12.2.3. By Applications
12.2.4. By Products and Services
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Applications
12.3.4. By Products and Services
12.3.5. By End User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Technology
13.2.3. By Applications
13.2.4. By Products and Services
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technology
13.3.3. By Applications
13.3.4. By Products and Services
13.3.5. By End User
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Technology
14.2.3. By Applications
14.2.4. By Products and Services
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technology
14.3.3. By Applications
14.3.4. By Products and Services
14.3.5. By End User
14.4. Key Takeaways
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Technology
15.2.3. By Applications
15.2.4. By Products and Services
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Technology
15.3.3. By Applications
15.3.4. By Products and Services
15.3.5. By End User
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Technology
16.2.3. By Applications
16.2.4. By Products and Services
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Technology
16.3.3. By Applications
16.3.4. By Products and Services
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2023
17.1.2.1. By Technology
17.1.2.2. By Applications
17.1.2.3. By Products and Services
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2023
17.2.2.1. By Technology
17.2.2.2. By Applications
17.2.2.3. By Products and Services
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2023
17.3.2.1. By Technology
17.3.2.2. By Applications
17.3.2.3. By Products and Services
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2023
17.4.2.1. By Technology
17.4.2.2. By Applications
17.4.2.3. By Products and Services
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2023
17.5.2.1. By Technology
17.5.2.2. By Applications
17.5.2.3. By Products and Services
17.5.2.4. By End User
17.6. UK
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2023
17.6.2.1. By Technology
17.6.2.2. By Applications
17.6.2.3. By Products and Services
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2023
17.7.2.1. By Technology
17.7.2.2. By Applications
17.7.2.3. By Products and Services
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2023
17.8.2.1. By Technology
17.8.2.2. By Applications
17.8.2.3. By Products and Services
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2023
17.9.2.1. By Technology
17.9.2.2. By Applications
17.9.2.3. By Products and Services
17.9.2.4. By End User
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2023
17.10.2.1. By Technology
17.10.2.2. By Applications
17.10.2.3. By Products and Services
17.10.2.4. By End User
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2023
17.11.2.1. By Technology
17.11.2.2. By Applications
17.11.2.3. By Products and Services
17.11.2.4. By End User
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2023
17.12.2.1. By Technology
17.12.2.2. By Applications
17.12.2.3. By Products and Services
17.12.2.4. By End User
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2023
17.13.2.1. By Technology
17.13.2.2. By Applications
17.13.2.3. By Products and Services
17.13.2.4. By End User
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2023
17.14.2.1. By Technology
17.14.2.2. By Applications
17.14.2.3. By Products and Services
17.14.2.4. By End User
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2023
17.15.2.1. By Technology
17.15.2.2. By Applications
17.15.2.3. By Products and Services
17.15.2.4. By End User
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2023
17.16.2.1. By Technology
17.16.2.2. By Applications
17.16.2.3. By Products and Services
17.16.2.4. By End User
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2023
17.17.2.1. By Technology
17.17.2.2. By Applications
17.17.2.3. By Products and Services
17.17.2.4. By End User
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2023
17.18.2.1. By Technology
17.18.2.2. By Applications
17.18.2.3. By Products and Services
17.18.2.4. By End User
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2023
17.19.2.1. By Technology
17.19.2.2. By Applications
17.19.2.3. By Products and Services
17.19.2.4. By End User
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2023
17.20.2.1. By Technology
17.20.2.2. By Applications
17.20.2.3. By Products and Services
17.20.2.4. By End User
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2023
17.21.2.1. By Technology
17.21.2.2. By Applications
17.21.2.3. By Products and Services
17.21.2.4. By End User
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2023
17.22.2.1. By Technology
17.22.2.2. By Applications
17.22.2.3. By Products and Services
17.22.2.4. By End User
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2023
17.23.2.1. By Technology
17.23.2.2. By Applications
17.23.2.3. By Products and Services
17.23.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Technology
18.3.3. By Applications
18.3.4. By Products and Services
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Agilent Technologies Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Axxam SpA
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Beckman Coulter Inc.
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Bio-Rad Laboratories Inc.
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Danaher Corporation
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. GE Healthcare
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Merck KGaA
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. PerkinElmer Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Tecan Group Ltd
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Thermo Fisher Scientific Inc.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
High Throughput Screening Market
